11. SHARE CAPITAL
Authorized
Unlimited number of common shares, without par value.
Issued
During the year ended February 29, 2024:
In February 2024, the Company issued 2,900,000 common shares in connection with the vesting and conversion of 2,900,000 restricted share units.
The Company issued 26,307 common shares in connection with the exercise of 26,307 warrants with a weighted average exercise price of $1.75 for total proceeds of $46,021. As a result, the Company transferred $33,706 representing the carrying value of the exercised warrants from reserves to share capital. The Company also issued 540,600 common shares in connection with the exercise of 540,600 stock options with a weighted average exercise price of $1.47 for total proceeds of $801,908. As a result, the Company transferred $561,349 representing the carrying value of the exercised options from reserves to share capital.
During the year ended February 28, 2023:
In June 2022, the Company issued 2,250,000 common shares of the Company at a fair value of $4,635,000 in relation to the acquisition of additional concessions in Falchani Property. (Note 10)
In January 2023, the Company issued 950,000 common shares of the Company at a fair value of $4,503,000 in relation to the royalty buyback on the TLC Project. (Note 10)
In January 2023, the Company issued 200,000 common shares of the Company at a fair value of $946,000 to acquire Maran Ventures Ltd. (Note 10)
The Company issued 2,966,282 common shares in connection with the exercise of 2,966,282 warrants with a weighted average exercise price of $3.15 for total proceeds of $9,343,053. As a result, the Company transferred $4,174,948 representing the carrying value of the exercised warrants from reserves to share capital. The Company also issued 3,442,589 common shares in connection with the exercise of 3,442,589 stock options with a weighted average exercise price of $1.32 for total proceeds of $4,583,392. As a result, the Company transferred $3,132,758 representing the carrying value of the exercised options from reserves to share capital.
Stock options
The Company has established an omnibus incentive plan (the "Incentive Plan") for directors, employees, and consultants, which provides for the grant of incentive stock options. Under the Incentive Plan, the exercise price of each option is determined by the Board, based upon the market price and subject to the policies of the Exchange. The aggregate number of shares issuable pursuant to options, and other securities granted under the Incentive Plan is limited to 10% of the Company's issued shares at the time of grant. The aggregate number of options granted to any one optionee in a 12-month period is limited to 5% of the issued shares of the Company.
26
American Lithium Corp. Notes to the Consolidated Financial Statements For the years ended February 29, 2024 and February 28, 2023 (Expressed in Canadian Dollars) |
11. SHARE CAPITAL (continued)
A summary of changes of stock options outstanding is as follows:
| | Options | | | Weighted average | |
| | | | | exercise price | |
| | | | | $ | |
Balance, February 28, 2022 | | 14,339,775 | | | 2.00 | |
Granted | | 1,800,000 | | | 4.10 | |
Exercised | | (3,442,589 | ) | | 1.32 | |
Cancelled/Expired | | (717,970 | ) | | 2.67 | |
Balance, February 28, 2023 | | 11,979,216 | | | 2.47 | |
Granted | | 75,000 | | | 2.73 | |
Exercised | | (540,600 | ) | | 1.47 | |
Forfeited | | (465,000 | ) | | 3.74 | |
Cancelled/Expired | | (159,850 | ) | | 3.37 | |
Balance, February 29, 2024 | | 10,888,766 | | | 2.46 | |
As at February 29, 2024, the following options were outstanding and exercisable:
| Number of options | | | Number of options | | | | | | | | | | |
| outstanding | | | exercisable | | | Exercise price | | | Remaining life | | | Expiry date | |
| | | | | | | $ | | | (years) | | | | |
| 166,750 | | | 166,750 | | | 2.24 | | | 0.15 | | | 23-Apr-24(1) | |
| 200,000 | | | 200,000 | | | 0.25 | | | 0.94 | | | 4-Feb-25 | |
| 1,729,167 | | | 1,729,167 | | | 1.28 | | | 1.55 | | | 17-Sep-25 | |
| 51,515 | | | 51,515 | | | 1.03 | | | 1.78 | | | 9-Dec-25 | |
| 5,758,334 | | | 5,758,334 | | | 2.17 | | | 2.28 | | | 10-Jun-26 | |
| 1,323,000 | | | 1,323,000 | | | 3.63 | | | 2.97 | | | 16-Feb-27 | |
| 250,000 | | | 250,000 | | | 1.91 | | | 3.35 | | | 4-Jul-27 | |
| 150,000 | | | 150,000 | | | 2.14 | | | 3.60 | | | 4-Oct-27 | |
| 1,185,000 | | | 1,185,000 | | | 4.85 | | | 3.93 | | | 2-Feb-28 | |
| 75,000 | | | 50,000 | | | 2.73 | | | 4.39 | | | 18-Jul-28 | |
| 10,888,766 | | | 10,863,766 | | | | | | | | | | |
(1) Subsequent to February 29, 2024, the stock options expired unexercised.
During the year ended February 29, 2024, the Company recorded share-based compensation of $2,862,913 (February 28, 2023 - $6,716,937) in relation to stock options.
During the year ended February 29, 2024, the weighted average fair value of stock options granted was $2.09 per stock option (February 28, 2023 - $3.04). Weighted average assumptions used in the Black-Scholes option pricing model for stock options granted during the years ended February 29, 2024, and February 28, 2023, were as follows: